NovoCure Ltd Quarterly Operating Income (Loss) in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NovoCure Ltd quarterly/annual Operating Income (Loss) history and growth rate from Q3 2014 to Q3 2024.
  • NovoCure Ltd Operating Income (Loss) for the quarter ending September 30, 2024 was -$32.1M, a 44.9% increase year-over-year.
  • NovoCure Ltd Operating Income (Loss) for the twelve months ending September 30, 2024 was -$159M, a 29.1% increase year-over-year.
  • NovoCure Ltd annual Operating Income (Loss) for 2023 was -$233M, a 160% decline from 2022.
  • NovoCure Ltd annual Operating Income (Loss) for 2022 was -$89.5M, a 102% decline from 2021.
  • NovoCure Ltd annual Operating Income (Loss) for 2021 was -$44.3M, a 246% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$159M -$32.1M +$26.2M +44.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 -$185M -$33.6M +$29.1M +46.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 -$214M -$41.5M +$18.7M +31.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$233M -$51.7M -$8.74M -20.3% Oct 1, 2023 Dec 31, 2023 10-Q 2024-10-30
Q3 2023 -$224M -$58.2M -$33.6M -137% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 -$190M -$62.7M -$41.5M -197% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 -$149M -$60.2M -$59.4M -7375% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$89.5M -$43M -$19.6M -83.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-23
Q3 2022 -$69.9M -$24.6M -$16.1M -188% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$53.9M -$21.1M -$8.83M -71.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 -$45.1M -$806K -$718K -816% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$44.3M -$23.4M -$35.5M -294% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$8.84M -$8.55M -$23.6M -157% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-23
Q2 2021 $14.7M -$12.3M -$19M -284% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-23
Q1 2021 $33.7M -$88K +$3.29M +97.4% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-23
Q4 2020 $30.4M $12.1M +$11.9M +7803% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $18.5M $15M +$11.2M +290% Jul 1, 2020 Sep 30, 2020 10-K 2023-02-23
Q2 2020 $7.3M $6.67M +$5.47M +458% Apr 1, 2020 Jun 30, 2020 10-K 2023-02-23
Q1 2020 $1.82M -$3.38M +$2.74M +44.7% Jan 1, 2020 Mar 31, 2020 10-K 2023-02-23
Q4 2019 -$914K $153K +$8.82M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$9.73M $3.86M +$9.1M Jul 1, 2019 Sep 30, 2019 10-K 2022-02-24
Q2 2019 -$18.8M $1.2M +$8.28M Apr 1, 2019 Jun 30, 2019 10-K 2022-02-24
Q1 2019 -$27.1M -$6.12M +$6.56M +51.7% Jan 1, 2019 Mar 31, 2019 10-K 2022-02-24
Q4 2018 -$33.7M -$8.66M -$4.16M -92.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$29.5M -$5.25M +$673K +11.4% Jul 1, 2018 Sep 30, 2018 10-K 2021-02-25
Q2 2018 -$30.2M -$7.09M +$8.45M +54.4% Apr 1, 2018 Jun 30, 2018 10-K 2021-02-25
Q1 2018 -$38.6M -$12.7M +$696K +5.21% Jan 1, 2018 Mar 31, 2018 10-K 2021-02-25
Q4 2017 -$39.3M -$4.51M +$13.4M +74.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$52.7M -$5.92M +$22.3M +79.1% Jul 1, 2017 Sep 30, 2017 10-K 2020-02-27
Q2 2017 -$75M -$15.5M +$21.7M +58.3% Apr 1, 2017 Jun 30, 2017 10-K 2020-02-27
Q1 2017 -$96.8M -$13.4M +$18.6M +58.1% Jan 1, 2017 Mar 31, 2017 10-K 2020-02-27
Q4 2016 -$115M -$17.9M +$12.7M +41.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$128M -$28.3M -$4.03M -16.6% Jul 1, 2016 Sep 30, 2016 10-K 2019-02-28
Q2 2016 -$124M -$37.2M -$10M -36.9% Apr 1, 2016 Jun 30, 2016 10-K 2019-02-28
Q1 2016 -$114M -$31.9M -$9.99M -45.5% Jan 1, 2016 Mar 31, 2016 10-K 2019-02-28
Q4 2015 -$104M -$30.6M Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 -$24.2M -$6.33M -35.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 -$27.2M Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 -$21.9M Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
Q3 2014 -$17.9M Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.